Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.91
+3.53%
Mkt Cap $648.89M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
Implied Upside
+237.5%
Consensus $6.43 vs current $1.91
NASDAQ·Healthcare·Biotechnology
$1.91
+3.53%
Mkt Cap $648.89M
Buy
6
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
+237.5%
Consensus $6.43 vs current $1.91